Relationship between tumor mutational burden, gene mutation status, and clinical characteristics in 340 cases of lung adenocarcinoma

Abstract Tumor mutational burden (TMB) is an emerging predictive marker of response to immune checkpoint inhibitor therapies. We evaluated the correlation between clinical indicators and high‐throughput sequencing results and TMB in lung adenocarcinoma patients, with the aim of finding simpler and m...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kai Ma, Fengxiang Huang, Yin Wang, Yan Kang, Qilong Wang, Jiaqi Tang, Panfeng Sun, Jiaojiao Lou, Ruiping Qiao, Jiming Si, Jian Cao, Lijun Miao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-11-01
coleção:	Cancer Medicine
Assuntos:	immune checkpoint inhibitors lung adenocarcinoma tumor mutational burden (TMB)
Acesso em linha:	https://doi.org/10.1002/cam4.4781
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!